Current Treatment of Metastatic Renal Cell Carcinoma With Xenogeneic Immune Ribonucleic Acid
Author:
Affiliation:
1. From the Departments of Surgery/Urology and Medical Oncology, Brigham and Women’s Hospital and the Dana Färber Cancer Institute, Harvard Medical School, Boston, Massachusetts
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference7 articles.
1. Prevention of death from metastases by immune RNA therapy;Wang;Science,1978
2. In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study;Richie;J. Urol.,1981
3. Fractionation of immune RNA capable of transferring tumor-specific cellular cytotoxicity;Wang;Cell. Immunol.,1978
4. Ribonucleic acid in "transformation" of lymphoid cells;Mannick;Science,1962
5. Transfer of tumor-specific immunity with RNA: inhibition of growth of murine tumor isografts;Ramming;J. Natl. Cancer Inst.,1971
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen;Vaccine;2009-12
2. Medical treatment of advanced renal cell carcinoma: present options and future directions;Cancer Treatment Reviews;1996-03
3. The management of renal cell carcinoma;Critical Reviews in Oncology/Hematology;1994-06
4. Immunotherapy in the Management of Metastatic Renal Cell Carcinoma;Tumours in Urology;1994
5. IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA;Urologic Clinics of North America;1993-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3